Amylyx Pharmaceuticals
AMLX
#6929
Rank
ยฃ0.33 B
Marketcap
ยฃ3.73
Share price
-6.53%
Change (1 day)
147.87%
Change (1 year)

Revenue for Amylyx Pharmaceuticals (AMLX)

Revenue in 2024 (TTM): ยฃ69.17 Million

According to Amylyx Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ64.98 Million. a decrease over the revenue in the year 2023 that were of ยฃ0.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amylyx Pharmaceuticals from 2021 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ69.62 M-76.71%
2023 ยฃ0.29 B1526.62%
2022 ยฃ18.37 M
2021 N/A